Even though Cologuard has long been successful, you will find concerns with Exact Sciences that investors cannot neglect. Very first, the corporate's top rated-line progress amount has long been decreasing. In the first quarter, Precise Sciences' revenue of $638 million improved by just below 6% calendar year more than year.These may be used to att